Nuclear receptors and circadian clock: Implications for inflammatory diseases

被引:0
|
作者
Duez, Helene [1 ]
Pourcet, Benoit [1 ]
机构
[1] Univ Lille, Inserm, CHU Lille, Inst pasteur Lille U1011 EGID, F-59000 Lille, France
来源
M S-MEDECINE SCIENCES | 2022年 / 38卷 / 8-9期
关键词
SHIFT WORK; EXPRESSION; BMAL1; ALPHA; RISK; COMPONENTS; IMMUNITY; RHYTHMS; PROTEIN;
D O I
10.1051/medsci/2022102
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The biological clock is a set of evolutionarily conserved "clock proteins" that generate circadian rhythms in behavior and physiological processes. The clock programs these processes at specific times of the day, allowing the organism to optimize its functions by anticipating predictable daily changes such as day/night, hence sleep/wake or feeding/fasting cycles. Modern lifestyle, i.e., exposure to light at night, shift work and irregular eating patterns and sleep schedules desynchronize the clocks residing in each organ. This dissonance is associated with an increased risk of developing various diseases such as cancer, metabolic, cardiovascular and chronic inflammatory diseases. The response to pathogens is circadian due to the rhythmic number and behavior of the immune cells. Thus, there is a rhythmic response to endotoxins and to infection by bacterial and viral pathogens. These oscillations are also observed in symptoms that are generally more severe in the morning in cardiovascular diseases or at night in asthma for example. Chronotherapy, i.e., the administration of a pharmacological compound at the most appropriate time of the day to optimize its efficacy and reduce side effects, has been used for a long time in the treatment of cancers, in particular colorectal cancers. However, it is still little considered in the management of cardiovascular or inflammatory diseases. A better understanding of biological rhythms and/or the targeting of certain clock genes, in particular nuclear receptors, by pharmacological compounds administered at the optimal time of day, represents a promising therapeutic avenue.
引用
收藏
页码:669 / 678
页数:10
相关论文
共 50 条
  • [41] Nuclear receptors REVERBα. and REVERBβ set the clock
    Teboul, Michele
    Delaunay, Franck
    M S-MEDECINE SCIENCES, 2012, 28 (8-9): : 689 - 692
  • [42] Redox regulation of circadian molecular clock in chronic airway diseases
    Sundar, Isaac K.
    Sellix, Michael T.
    Rahman, Irfan
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 119 : 121 - 128
  • [43] The role of clock genes and circadian rhythm in the development of cardiovascular diseases
    Takeda, Norihiko
    Maemura, Koji
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (17) : 3225 - 3234
  • [44] Circadian clock genes as promising therapeutic targets for autoimmune diseases
    Xiang, Kun
    Xu, Zhiwei
    Hu, Yu-Qian
    He, Yi-Sheng
    Wu, Guo-Cui
    Li, Tian-Yu
    Wang, Xue-Rong
    Ding, Li-Hong
    Zhang, Qin
    Tao, Sha-Sha
    Ye, Dong-Qing
    Pan, Hai-Feng
    Wang, De-Guang
    AUTOIMMUNITY REVIEWS, 2021, 20 (08)
  • [45] Nuclear receptors in neurodegenerative diseases
    Skerrett, Rebecca
    Malm, Tarja
    Landreth, Gary
    NEUROBIOLOGY OF DISEASE, 2014, 72 : 104 - 116
  • [46] Editorial: The Circadian Clock and immune system interplay in infectious diseases
    Chertoff, Mariela
    Marpegan, Luciano
    Pregi, Nicolas
    Paladino, Natalia
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [47] Circadian Clock Dysregulation Linked to Obesity-Related Diseases
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (01): : 19 - 19
  • [48] Circadian clock-based therapeutics in chronic pulmonary diseases
    Giri, Allan
    Rahman, Irfan
    Sundar, Isaac Kirubakaran
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (12) : 1014 - 1029
  • [49] The role of clock genes and circadian rhythm in the development of cardiovascular diseases
    Norihiko Takeda
    Koji Maemura
    Cellular and Molecular Life Sciences, 2015, 72 : 3225 - 3234
  • [50] Nuclear Receptors in Health and Diseases
    Xu, Pengfei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)